First-line Immunotherapy in Metastatic Urothelial Carcinoma

被引：3
|
作者：
Ghatalia, Pooja [1 ]
Zibelman, Matthew [1 ]
Geynisman, Daniel M. [1 ]
Plimack, Elizabeth R. [1 ]
机构：
[1] Fox Chase Canc Ctr, Dept Hematol Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA
来源：
EUROPEAN UROLOGY FOCUS | 2020年 / 6卷 / 01期
关键词：
CISPLATIN; CHEMOTHERAPY; ATEZOLIZUMAB; METHOTREXATE; VINBLASTINE; MULTICENTER; DOXORUBICIN; TRIAL;
D O I：
10.1016/j.euf.2019.04.015
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：45 / 47
页数：3
相关论文
共 50 条
  • [21] Optimal Number of Cycles of First-line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
    Minato, Akinori
    Ohno, Daichi
    Murooka, Kazuki
    Okumura, Yutaka
    Takaba, Tomohisa
    Higashijima, Katsuyoshi
    Nagata, Yujiro
    Tomisaki, Ikko
    Harada, Kenichi
    Fujimoto, Naohiro
    IN VIVO, 2024, 38 (04): : 1927 - 1934
  • [22] Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.
    Tural, Deniz
    Olmez, Omer Fatih
    Sumbul, Ahmet Taner
    Artac, Mehmet
    Ozhan, Nail
    Akar, Emre
    Cakar, Burcu
    Kostek, Osman
    Ekenel, Meltem
    Coskun, Hasan Senol
    Selcukbiricik, Fatih
    Keskin, Ozge
    Turkoz, Fatma Paksoy
    Oruc, Kerem
    Bayram, Selami
    Yilmaz, Ugur
    Bilgetekin, Irem
    Yildiz, Birol
    Sendur, Mehmet Ali Nahit
    Erman, Mustafa
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [23] First-line chemoimmunotherapy for metastatic thymic carcinoma
    Andreas, V. J.
    Alexander, M.
    Rogers, J.
    Faltys, M.
    Bowyer, S. E.
    Warburton, L.
    Fantoni, A.
    Clay, T. D.
    Antippa, P.
    Solomon, B.
    John, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S1679 - S1680
  • [24] Can Oncogenic Driver Alterations be Responsible for the Lack of Immunotherapy Efficacy in First-line Advanced Urothelial Carcinoma?
    Kartolo, Adi
    Robinson, Andrew
    Badillo, Francisco E. Vera
    EUROPEAN UROLOGY, 2023, 83 (01) : 1 - 2
  • [25] Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution
    Kawashima, Atsunari
    Ishizuya, Yu
    Yamamoto, Yoshiyuki
    Kato, Taigo
    Hatano, Koji
    Nonomura, Norio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (08) : 1096 - 1104
  • [26] Treatment options after first-line immunotherapy in metastatic NSCLC
    Santos, Edgardo S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (03) : 221 - 228
  • [27] Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding
    Apolo, Andrea B.
    Michaels-Igbokwe, Christine
    Simon, Nicholas I.
    Benjamin, David J.
    Farrar, Mallory
    Hepp, Zsolt
    Mucha, Lisa
    Heidenreich, Sebastian
    Cutts, Katelyn
    Krucien, Nicolas
    Ramachandran, Natasha
    Gore, John L.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2025, 18 (01): : 77 - 87
  • [28] First-line versus second-line immunotherapy in recurrent/metastatic squamous cell carcinoma of the head and neck
    Even, C.
    Torossian, N.
    Ibrahim, T.
    Martin, N.
    Badis, L. Mayache
    Ferrand, F. R.
    Iacob, M.
    Guigay, J.
    Le Tourneau, C.
    Daste, A.
    Saada-Bouzid, E.
    Saleh, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] Phase II trial of gemcitabine and cisplatin plus ipilimumab as first-line treatment for metastatic urothelial carcinoma
    Gartrell, Benjamin Adam
    Hahn, Noah M.
    Hutson, Thomas E.
    Sonpavde, Guru
    Hauke, Ralph J.
    Starodub, Alexander
    Small, Alexander C.
    Tsao, Che-Kai
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice
    Naito, Renato
    Izumi, Kouji
    Mizokami, Atsushi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 986 - 990
12345